Pancreatogastrostomy versus pancreatojejunostomy for RECOnstruction after partial PANCreatoduodenectomy – A randomized controlled trial

Pancreatogastrostomy versus pancreatojejunostomy for RECOnstruction after partial PANCreatoduodenectomy – A randomized controlled trial - RECOPANC

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00000767

Enrollment

438

Registered

2011-03-23

Start date

2011-06-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C25.0 K86.1

Interventions

Group 1: Pancreatojejunostomy Group 2: Pancreatogastrostomy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: -Patients scheduled for elective partial pancreaticoduodenectomy -Age = 18 years -Written informed consent

Exclusion criteria

Exclusion criteria: Participation in another intervention-trial with interference of intervention and outcome of this study Expected lack of compliance

Design outcomes

Primary

Measure	Time frame
postoperative pancreatic fistula (Grade B or C)defined according to International Study Group of Pancreatic Surgery, ISGPS within 30 days after reconstruction	—

Secondary

Measure	Time frame
delayed gastric emptying of grade B or C (ISGPS definition) during hospital stay - postpancreatectomy hemorrhage (ISGPS definition) - postoperative pancreatic fistula of grade A (ISGPS definition)30 days post-OP - postoperative hospital stay - operation time - parameters of endocrine and exocrine pancreatic function and Quality of Life (EORTC QLQ-C30 and PAN 26 subscores) 30 days, 6 and 12 months after the operation - in-hospital mortality	—

Measure

Time frame

delayed gastric emptying of grade B or C (ISGPS definition) during hospital stay - postpancreatectomy hemorrhage (ISGPS definition) - postoperative pancreatic fistula of grade A (ISGPS definition)30 days post-OP - postoperative hospital stay - operation time - parameters of endocrine and exocrine pancreatic function and Quality of Life (EORTC QLQ-C30 and PAN 26 subscores) 30 days, 6 and 12 months after the operation - in-hospital mortality

—

Countries

Germany

Contacts

Public ContactInga Wegener

Studienzentrum der Deutschen Gesellschaft für Chirurgie Chirurgische Universitätsklink Heidelberg

inga.wegener@med.uniklinik-heidelberg.de06221-565245

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 26, 2026